Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis

Preclinical and human studies suggest that hippocampal dysfunction is a key factor in the onset of psychosis. People at Clinical High Risk for psychosis (CHR-P) present with a clinical syndrome that can include social withdrawal and have a 20–35% risk of developing psychosis in the next 2 years. Rec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuropsychopharmacology
Egile Nagusiak: Davies, Cathy, Paloyelis, Yannis, Rutigliano, Grazia, Cappucciati, Marco, De Micheli, Andrea, Ramella-Cravaro, Valentina, Provenzani, Umberto, Antoniades, Mathilde, Modinos, Gemma, Oliver, Dominic, Stahl, Daniel, Murguia, Silvia, Zelaya, Fernando, Allen, Paul, Shergill, Sukhi, Morrison, Paul, Williams, Steve, Taylor, David, McGuire, Philip, Fusar-Poli, Paolo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784972/
https://ncbi.nlm.nih.gov/pubmed/30626906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0311-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak